Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Dr ...
ShareThe recent wave of delistings from the Nigerian Exchange (NGX) by notable companies such as Flour Mills of Nigeria (FMN) and GlaxoSmithKline (GSK) has sparked conversations among investors, ...
The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
Hosted on MSN1d
Is there a vaccine for H5N1? What we know as first person with severe case of bird flu died in United StatesThe H5N1 bird flu has been reported to have caused the death of a patient in Louisiana. Such a case poses a significant ...
Berenberg Bank analyst Luisa Hector maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.00.
The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.
A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.
In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback